We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Long-Awaited CMO Guidance Advises Use of Quality Agreements
FDA’s Long-Awaited CMO Guidance Advises Use of Quality Agreements
May 31, 2013
The FDA on May 24 issued long-awaited guidance on how drugmakers and their contract manufacturing partners can best use quality agreements to ensure safe and effective drugs.